Renaissance Technologies
ETRM

Renaissance Technologies’s EnteroMedics Inc. ETRM Stock Holding History

Renaissance Technologies’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-162,765
Closed -$326K – 3648
2016
Q4 		$326K Buy
162,765
+106,602
+190% +$559K ﹤0.01% 2891
2016
Q3 		$531K Buy
56,163
+52,584
+1,469% +$714K ﹤0.01% 2794
2016
Q2 		$73K Buy
+3,579
New +$164K ﹤0.01% 3202
2013
Q4 		– Sell
-292
Closed -$382K – 3274
2013
Q3 		$382K Buy
+292
New +$340K ﹤0.01% 2394

Other funds holding ETRM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Renaissance Technologies's ETRM Position: Q1 2017 in Review

Renaissance Technologies sold out of EnteroMedics Inc. (ETRM) in Q1 2017, closing a stake of 162,765 shares — an estimated $326K sold.

Renaissance Technologies first reported a position in ETRM in Q3 2013 and held it in 4 quarters. The position peaked at $531K in Q3 2016. 26 funds tracked by Wall St. Rank hold ETRM as of Q1 2017.

  • Renaissance Technologies reported no remaining EnteroMedics Inc. position as of Q1 2017 after selling out during the quarter.
  • Renaissance Technologies sold 162,765 EnteroMedics Inc. shares in Q1 2017, an estimated $326K.
  • Renaissance Technologies first reported a position in EnteroMedics Inc. in Q3 2013 and held it in 4 quarters.
  • Renaissance Technologies's EnteroMedics Inc. position peaked at $531K in Q3 2016.
  • 26 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2017.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.